Metabolic syndrome and risk of complications in body contouring surgery. A systematic review

Nº de DOI: 10.34896/RSI.2026.46.50.001

 

AUTHORS

1. Dakmar Doménica Molina Maldonado. General Practitioner with a Master’s Degree in Community Nutrition and Dietetics. Affiliated with Hospital Básico SERMES. Graduate of Universidad de las Américas. Based in Latacunga, Ecuador. https://orcid.org/0009-0009-5298-0964
2. Sofía Paulina Arteaga Criollo. General Practitioner. Affiliated with the IESS Comité del Pueblo Specialty Center. Graduate of Universidad Central del Ecuador. Based in Quito, Ecuador. https://orcid.org/0009-0009-1661-1942
3. Andreina Stefania Aguilar Lara. General Practitioner with a Master’s Degree in Occupational Safety and Health. Affiliated with Pontificia Universidad Católica del Ecuador. Graduate of Universidad de Cuenca. Based in Esmeraldas, Ecuador. https://orcid.org/0009-0006-8036-1878
4. Lucy Inés Sinche Méndez. General Practitioner with a Master’s Degree in Occupational Safety and Health. Affiliated with Hospital General Guasmo Sur. Graduate of Universidad de Guayaquil. Based in Guayaquil, Ecuador. https://orcid.org/0009-0009-4266-6875

 

ABSTRACT

Introduction: The worldwide prevalence of obesity and its associated cardiometabolic derangements has risen sharply over the past three decades, and metabolic syndrome (MetS) the clustering of central obesity, hypertension, dyslipidemia, and hyperglycemia now affects roughly one in four adults globally. As bariatric and pharmacologic weight-loss interventions become more widely available, and as the aesthetic and reconstructive demand for abdominoplasty, panniculectomy, liposuction, brachioplasty, and post-bariatric body-lift procedures continues to expand, plastic surgeons are increasingly confronted with surgical candidates who carry some or all of the components that define MetS.

Objective: To systematically review and synthesize the available peer-reviewed literature examining the relationship between metabolic syndrome, or its individual components, and postoperative complications following body contouring surgery.

Method: A structured search of the biomedical literature was performed to identify original clinical research, large administrative-database analyses, and systematic reviews published in indexed, peer-reviewed journals addressing metabolic syndrome, obesity, diabetes, or related cardiometabolic risk factors in the context of abdominoplasty, panniculectomy, liposuction, brachioplasty, and post-bariatric body contouring. Twenty-one studies meeting predefined eligibility criteria were included in the qualitative synthesis.

Results: Obesity and its individual metabolic components are consistently associated with a dose-dependent increase in wound-related morbidity seroma, hematoma, surgical-site infection, and dehiscence across single-institution cohorts. Large administrative-database analyses that rely on surrogate, code-based definitions of MetS generally show a more modest effect, most often limited to a longer hospital stay and a higher 30-day readmission rate rather than a statistically higher rate of major complications. Venous thromboembolism (VTE) remains a rare but disproportionately obesity-associated event, and existing risk-stratification instruments such as the Caprini model have imperfect predictive value in this population. Chronic low-grade inflammation, adipokine dysregulation, and microvascular compromise driven by expanded and dysfunctional adipose tissue provide a plausible biological link between MetS and impaired wound healing.

Conclusions: Metabolic syndrome and its individual components meaningfully influence the safety profile of body contouring surgery, although the magnitude of the observed risk depends heavily on how MetS is defined and measured across studies. Preoperative metabolic optimization, individualized thromboprophylaxis, staged rather than combined procedures in higher-risk patients, and the adoption of standardized diagnostic criteria for MetS in future research are warranted to improve outcomes and the comparability of evidence in this field.

KEY WORDS

Metabolic syndrome, body contouring, abdominoplasty, panniculectomy, lipectomy, obesity, postoperative complications, venous thromboembolism, wound healing, bariatric surgery.

RESUMEN

Introducción: La prevalencia mundial de la obesidad y sus alteraciones cardiometabólicas asociadas ha aumentado drásticamente en las últimas tres décadas; asimismo, el síndrome metabólico (SM) —definido como la agrupación de obesidad central, hipertensión, dislipidemia e hiperglucemia— afecta actualmente a aproximadamente uno de cada cuatro adultos en todo el mundo. A medida que se generaliza el acceso a intervenciones bariátricas y farmacológicas para la pérdida de peso, y que crece la demanda estética y reconstructiva de procedimientos como abdominoplastia, paniculectomía, liposucción, braquioplastia y cirugía de contorno corporal posbariátrica, los cirujanos plásticos se enfrentan cada vez con mayor frecuencia a candidatos quirúrgicos que presentan algunos o todos los componentes que definen el SM.

Objetivo: Realizar una revisión sistemática y una síntesis de la literatura científica revisada por pares disponible que examine la relación entre el síndrome metabólico (o sus componentes individuales) y las complicaciones posoperatorias tras la cirugía de contorno corporal.

Método: Se llevó a cabo una búsqueda estructurada de literatura biomédica para identificar investigaciones clínicas originales, análisis de grandes bases de datos administrativas y revisiones sistemáticas publicadas en revistas indexadas y revisadas por pares que abordaran el síndrome metabólico, la obesidad, la diabetes o factores de riesgo cardiometabólico relacionados en el contexto de la abdominoplastia, la paniculectomía, la liposucción, la braquioplastia y el contorno corporal posbariátrico. Se incluyeron veintiún estudios que cumplían con los criterios de elegibilidad preestablecidos para la síntesis cualitativa.

Resultados: La obesidad y sus componentes metabólicos individuales se asocian de manera constante con un aumento —dependiente de la dosis— de la morbilidad relacionada con la herida (seroma, hematoma, infección del sitio quirúrgico y dehiscencia) en cohortes de centros únicos. Los análisis de grandes bases de datos administrativas, que se basan en definiciones indirectas del síndrome metabólico (SM) mediante códigos, suelen mostrar un efecto más modesto, limitado generalmente a una estancia hospitalaria más prolongada y una mayor tasa de reingreso a los 30 días, en lugar de una tasa estadísticamente superior de complicaciones mayores. El tromboembolismo venoso (TEV) sigue siendo un evento poco frecuente pero desproporcionadamente asociado a la obesidad, y las herramientas de estratificación de riesgo existentes, como el modelo de Caprini, presentan un valor predictivo imperfecto en esta población. La inflamación crónica de bajo grado, la desregulación de las adipocinas y el compromiso microvascular —provocados por un tejido adiposo expandido y disfuncional— constituyen un vínculo biológico plausible entre el SM y la alteración de la cicatrización de heridas.

Conclusiones: El síndrome metabólico y sus componentes individuales influyen de manera significativa en el perfil de seguridad de la cirugía de contorno corporal, si bien la magnitud del riesgo observado depende en gran medida de cómo se defina y mida el SM en los distintos estudios. Resulta necesario implementar la optimización metabólica preoperatoria, la tromboprofilaxis individualizada, la realización de procedimientos por etapas en lugar de combinados en pacientes de mayor riesgo, y la adopción de criterios diagnósticos estandarizados para el SM en futuras investigaciones, con el fin de mejorar los resultados y la comparabilidad de la evidencia en este campo.

PALABRAS CLAVE

Síndrome metabólico, contorno corporal, abdominoplastia, paniculectomía, lipectomía, obesidad, complicaciones posoperatorias, tromboembolismo venoso, cicatrización de heridas, cirugía bariátrica.

INTRODUCTION

The worldwide prevalence of obesity and its associated cardiometabolic derangements has risen sharply over the past three decades, and metabolic syndrome (MetS) the clustering of central obesity, hypertension, dyslipidemia, and hyperglycemia now affects roughly one in four adults globally. As bariatric and pharmacologic weight-loss interventions become more widely available, and as the aesthetic and reconstructive demand for abdominoplasty, panniculectomy, liposuction, brachioplasty, and post-bariatric body-lift procedures continues to expand, plastic surgeons are increasingly confronted with surgical candidates who carry some or all of the components that define MetS.

OBJECTIVE

The primary objective of this systematic review is to characterize, through a critical appraisal of the peer-reviewed literature, the association between metabolic syndrome as a composite diagnosis or through its individual components of central obesity, arterial hypertension, dyslipidemia, and impaired glucose regulation and the incidence, severity, and type of complications occurring after body contouring surgery, including abdominoplasty, panniculectomy, brachioplasty, thighplasty, and liposuction, whether performed as an isolated aesthetic procedure or following massive weight loss (MWL) after bariatric surgery. Secondary objectives include: (1) summarizing how MetS has been operationally defined across the surgical outcomes literature; (2) describing the specific complication categories most strongly linked to cardiometabolic dysregulation, including wound-healing disturbances and venous thromboembolic events; (3) identifying the plausible pathophysiological mechanisms connecting adipose tissue dysfunction to impaired surgical healing; and (4) deriving practical, evidence-informed recommendations for preoperative risk stratification, patient optimization, and perioperative management of patients with MetS who are candidates for body contouring procedures.

METHODOLOGY

Study design:

This work was conducted as a qualitative systematic review of the peer-reviewed surgical and endocrinological literature, structured in a manner consistent with the general principles of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) framework, given the clinical heterogeneity of the primary studies (retrospective cohorts, large administrative-database analyses, and narrative or systematic reviews), which precluded formal quantitative pooling of effect estimates.

Search strategy:

A structured search of indexed biomedical bibliographic sources (including PubMed/MEDLINE-indexed journals, Springer Nature, Elsevier/ScienceDirect, and Oxford University Press journal platforms) was performed for articles published through 2025. Search terms were combined using Boolean operators and included, among others: «metabolic syndrome,» «obesity,» «diabetes mellitus,» «cardiometabolic,» combined with «body contouring,» «abdominoplasty,» «panniculectomy,» «lipectomy,» «liposuction,» «brachioplasty,» «thighplasty,» «massive weight loss,» «bariatric surgery,» «postoperative complications,» «wound healing,» «surgical site infection,» and «venous thromboembolism.»

The search process proceeded iteratively: an initial broad search identified candidate records, after which more targeted secondary searches were performed for each thematic subdomain relevant to the review question the formal definition and global epidemiology of metabolic syndrome, wound-healing outcomes after abdominoplasty and panniculectomy, complication profiles stratified by body mass index and diabetes status, venous thromboembolism risk assessment and prophylaxis specific to plastic surgery, liposuction safety data, and the molecular pathophysiology linking adipose tissue dysfunction to impaired healing. This staged approach was chosen deliberately over a single combined query, since combined multi-concept searches in this literature tend to surface predominantly high-level or tangential results and under-represent the more specific, procedure-level outcome data needed for a clinically meaningful synthesis.

Eligibility criteria:

Inclusion criteria were: (1) original research articles, database cohort analyses, or systematic reviews published in a peer-reviewed journal with an assigned Digital Object Identifier (DOI); (2) human subjects; (3) explicit evaluation of metabolic syndrome, obesity, diabetes, hypertension, dyslipidemia, or a composite cardiometabolic burden as an exposure or risk factor; and (4) a body contouring procedure (abdominoplasty, panniculectomy, liposuction, brachioplasty, thighplasty, body lift, or combinations thereof) as the surgical context, with a defined postoperative complication outcome. Exclusion criteria were: case reports with fewer than ten patients, conference abstracts without an associated full-text peer-reviewed publication, non-journal sources such as books or book chapters, studies published only in non-English languages without an available English abstract sufficient for data extraction, and articles for which no verifiable DOI could be confirmed.

Study selection and data extraction:

Titles and abstracts were screened for relevance, followed by full-text review of potentially eligible articles. For each included study, the following data were extracted: first author and year, journal, study design, sample size, the definition of metabolic syndrome or cardiometabolic risk used, the specific body contouring procedure(s) evaluated, and the principal complication outcomes with associated effect estimates (odds ratios, percentages, or descriptive comparisons) where reported. Twenty-one articles satisfied all eligibility criteria and were retained for qualitative synthesis; these spanned publication years 2008 through 2025 and included retrospective single-institution cohorts, large national administrative-database analyses (e.g., the American College of Surgeons National Surgical Quality Improvement Program [NSQIP], the PearlDiver claims database, and the TriNetX federated electronic health record network), narrative reviews of pathophysiology, and systematic reviews of thromboprophylaxis and liposuction safety.

Quality and risk-of-bias considerations:

Because the included evidence base is composed predominantly of retrospective cohort and administrative-database studies, each article was qualitatively appraised for study design, sample size, adequacy of confounder adjustment, and the specificity of the metabolic syndrome definition employed, in order to contextualize the strength of the conclusions that could reasonably be drawn. Studies using validated, harmonized diagnostic criteria for metabolic syndrome were distinguished from those relying on surrogate, code-based definitions (for example, a body mass index threshold combined with documented pharmacologic treatment for diabetes and hypertension), since this distinction has important implications for the interpretation of the pooled findings described below.

Data synthesis:

Given the marked heterogeneity in study design, patient population, procedure type, and outcome definitions across the included articles, a formal quantitative meta-analysis with pooled effect estimates was not considered methodologically appropriate. Instead, findings were synthesized narratively and organized thematically around four clinically oriented domains: (1) the prevalence and definitional variability of metabolic syndrome in body-contouring populations; (2) wound-healing and infectious complications; (3) venous thromboembolic events; and (4) the underlying pathophysiological mechanisms connecting adipose tissue dysfunction to impaired surgical healing. Where multiple studies reported quantitatively comparable outcomes (for example, odds ratios for wound complications stratified by BMI category), these were presented side by side to illustrate consistency or divergence in the underlying signal, without combining them into a single summary statistic.

RESULTS

Overview of included studies:

Twenty-one studies met the eligibility criteria for this review. The evidence base comprised single-institution retrospective cohorts of abdominoplasty and panniculectomy patients, large administrative-database analyses drawn from NSQIP, PearlDiver, and TriNetX, systematic reviews addressing liposuction complications and venous thromboembolism (VTE) chemoprophylaxis, and mechanistic reviews of obesity-related wound-healing pathophysiology. Sample sizes ranged from fewer than 100 patients in focused single-center cohorts to more than 240,000 patients in the largest claims-database analysis.

Definitions of metabolic syndrome across the literature:

The harmonized diagnostic criteria for metabolic syndrome requiring three of five components (elevated waist circumference, elevated triglycerides, reduced high-density lipoprotein cholesterol, elevated blood pressure, and elevated fasting glucose) represent the internationally accepted reference standard¹. However, few of the body-contouring outcome studies identified in this review applied these harmonized criteria in full. Instead, most large database studies operationalized MetS as a surrogate composite of body mass index (BMI) greater than 30 kg/m2 together with documented pharmacologic treatment for diabetes mellitus and hypertension, reflecting the limitations of administrative coding data, which frequently lack waist circumference and lipid panel information^4,5. This definitional heterogeneity complicates direct comparison across studies and likely underestimates the true prevalence of formally diagnosed MetS in these surgical cohorts.

Prevalence of metabolic syndrome and obesity in body-contouring populations:

Metabolic syndrome has become a global public health problem, with contemporary estimates suggesting that it affects approximately one-quarter of adults worldwide, driven principally by insulin resistance, visceral adiposity, and chronic low-grade inflammation, and closely paralleling rising rates of obesity and physical inactivity². Within body-contouring populations specifically, hypertension, obesity, and diabetes were identified as the three most common preoperative comorbidities in a PearlDiver analysis of 243,886 patients undergoing panniculectomy, abdominoplasty, brachioplasty, thighplasty, and breast procedures between 2010 and 2021⁹. Similarly, cohort studies of abdominoplasty populations have reported obesity prevalence ranging from 14% to more than 50%, depending on whether the population included post-bariatric massive-weight-loss (MWL) patients^6,7,8.

Wound-related complications and the obesity–diabetes gradient:

The most consistent and reproducible finding across the reviewed literature is a dose-dependent relationship between increasing body mass index and the incidence of wound-related complications following body contouring surgery. In a cohort of 129 patients undergoing a single body-contouring procedure, minor complications rose from 3.3% in the ideal-weight group to 46.9% in the severely morbidly obese group, and major complications rose correspondingly from 6.6% to 43.7%, with obese, morbidly obese, and severely morbidly obese patients demonstrating odds ratios of 6.43, 5.54, and 19.80, respectively, for minor or major complications relative to ideal-weight patients¹⁰. In a retrospective analysis of 191 abdominoplasty patients, obesity and preoperative BMI emerged as independent risk factors for overall complications (odds ratio 8.3 and 1.3, respectively), minor complications (odds ratio 7.4 and 1.3), and seroma formation (odds ratio 4.5 and 1.2), while diabetes independently predicted major complications (odds ratio 4.6); notably, a prior history of bariatric surgery itself was not an independent risk factor once obesity was accounted for⁷. A separate cohort of 235 abdominoplasty patients similarly implicated BMI of 30 kg/m2 or higher, diabetes, hypertension, and active smoking among the principal predisposing factors for complications, while emphasizing the absence of clear, universally accepted guidelines for surgical candidate selection in this population.[8]

In the PearlDiver database analysis of 243,886 patients, logistic regression modeling confirmed that obesity, tobacco use, diabetes, and hypertension were each independently associated with increased odds of wound dehiscence, hematoma, and surgical-site infection, the three most frequent postoperative complications identified across all body contouring procedure types⁹. A more recent single-institution study of 594 abdominoplasty and panniculectomy patients specifically examined glycemic control, finding a surgical-site infection rate of 24.2% overall; however, no statistically significant differences in outcomes were observed across HbA1c strata or by diabetic medication regimen, suggesting that the relationship between glycemic status and wound complications may be more complex than a simple linear threshold effect and that diabetes duration, vascular disease burden, and other unmeasured factors may also contribute⁶.

Findings from large national database analyses using composite MetS definitions

When metabolic syndrome was evaluated as a composite diagnosis using NSQIP data, the observed effect on complication rates was more modest than that seen for obesity or diabetes analyzed individually. In a propensity-score-matched analysis of patients undergoing concurrent abdominoplasty and panniculectomy identified from the ACS-NSQIP database, no statistically significant differences were observed between MetS and non-MetS cohorts in 30-day wound complications, mild systemic complications, or severe systemic complications; however, patients with MetS experienced a significantly longer hospital length of stay (approximately 2.3–2.4 days versus 1.6–1.7 days) and a significantly higher 30-day readmission rate (11.9% versus 6.5%, odds ratio 1.96, 95% confidence interval 1.09–3.51), driven predominantly by medical rather than surgical causes for readmission.[4] The authors of this analysis concluded that abdominal body contouring remains a reasonably safe option for well-selected patients with MetS, while cautioning that the observed increase in length of stay and readmission may carry meaningful downstream cost and resource-utilization implications for health systems⁴. Earlier work examining metabolic syndrome specifically in the context of panniculectomy similarly identified MetS, defined as obesity plus at least two of diabetes, hypertension, hypertriglyceridemia, or reduced high-density lipoprotein cholesterol, as a well-established general surgical risk factor, while noting that obese patients are particularly predisposed to developing the syndrome in the first place⁵.

Massive weight loss patients and post-bariatric body contouring:

Patients presenting for body contouring after massive weight loss constitute a distinct and higher-risk subgroup, owing to residual comorbidities, nutritional deficiencies, and the frequent need for multiple concurrent or staged procedures. In a cohort of 450 body-contouring patients, MWL status was a significant independent predictor of wound problems (odds ratio 2.69), and the amount of weight lost (greater than 100 pounds, odds ratio 3.98) and the method by which weight was lost (gastric bypass conferring a higher risk, odds ratio 3.01, than restrictive procedures or diet and exercise) further modulated this risk¹¹. By contrast, a more recent analysis of perioperative laboratory markers in 59 patients undergoing 117 body-contouring procedures after gastric bypass, sleeve gastrectomy, or gastric banding found no clinically relevant, procedure-independent laboratory abnormalities that would flag particular perioperative risk, concluding that body-contouring surgery after bariatric intervention is generally safe from a laboratory-marker standpoint, despite correlations between resection weight, drain output, and certain nutritional markers such as vitamin D and B-vitamin levels³. Taken together, these findings suggest that the elevated complication risk observed in MWL patients relates more to the cumulative burden of weight-loss history, residual excess skin, and multiple concurrent procedures than to a discrete, easily measurable laboratory abnormality.

Venous thromboembolism:

Venous thromboembolism, although uncommon, remains among the most feared complications of body contouring surgery because of its potential lethality. Obesity independently increases the relative risk of deep vein thrombosis by approximately 2.5-fold, and this risk is compounded in body-contouring patients by circumferential procedures, prolonged operative time, and immobility¹³. A systematic review of 31 publications examining VTE chemoprophylaxis specifically in massive-weight-loss patients undergoing body contouring found that the incidence of VTE for any individual procedure was generally too low to reach statistical significance, though hematoma rates were significantly higher in patients undergoing a single procedure with chemoprophylaxis (8.7%) compared with those undergoing combined procedures (4.2%), highlighting the inherent trade-off between thromboprophylaxis and bleeding risk that must be individualized in this population¹². The Caprini 2005 risk assessment model remains the most widely validated and recommended tool for VTE risk stratification in plastic surgery, endorsed by professional society task forces; however, critical appraisal of simulation data has noted that the majority of VTE events occur in patients with relatively low Caprini scores (six or below), raising questions about the discriminative value of risk-stratification instruments used in isolation and underscoring the importance of clinical judgment alongside formal scoring^14,15. Comprehensive, procedure-specific mechanical and chemoprophylaxis algorithms combining early ambulation, intermittent pneumatic compression, and selective pharmacologic prophylaxis in higher-risk patients undergoing lipoabdominoplasty have been proposed as a pragmatic approach to this uncertainty¹⁵. Outside the plastic surgery literature, the implementation of an electronic health record-based VTE risk-stratification tool has been shown to reduce postoperative VTE events across surgical specialties at a single academic medical center, supporting the broader principle that systematic, protocolized risk assessment, rather than reliance on a single scoring instrument, improves outcomes²⁰.

Liposuction-specific findings:

Liposuction, whether performed alone or combined with abdominoplasty, carries its own distinct complication profile. A systematic review of sixteen studies published between 2016 and 2021 reported an overall mortality rate ranging from 0% to 0.06%, with venous thromboembolism, hematoma, seroma, and hyperpigmentation representing the predominant complications; critically, complication rates were consistently higher when liposuction was combined with other procedures such as abdominoplasty or fat grafting than when performed in isolation¹⁶. This finding reinforces a recurring theme across the reviewed literature: cumulative surgical burden, rather than any single metabolic derangement in isolation, appears to be a major driver of complication risk in patients with obesity or MetS undergoing combined body-contouring operations.

Comparative risk across procedure types:

The magnitude of MetS- and obesity-related risk appears to vary meaningfully by the specific body-contouring procedure performed. Abdominal procedures abdominoplasty and panniculectomy carry the largest and most consistently reported burden of wound-related complications in the reviewed literature, likely reflecting the combination of extensive undermining, a long incisional length, and the direct anatomic overlap between the surgical field and the panniculus most affected by central, visceral adiposity^6,7,8,9,10. By contrast, the PearlDiver analysis spanning panniculectomy, abdominoplasty, brachioplasty, thighplasty, and breast procedures found that while obesity, tobacco use, diabetes, and hypertension increased the odds of wound dehiscence, hematoma, and infection across the cohort as a whole, the absolute complication burden was concentrated disproportionately among abdominally based procedures rather than distributed evenly across all body regions⁹. Similarly, in the laboratory-marker analysis of massive-weight-loss patients undergoing a mixture of abdominoplasty, thigh lift, mammaplasty, brachioplasty, and upper body lift procedures, abdominoplasty was both the most frequently performed procedure and the one associated with the largest resection weight and drain output, both of which correlated with perioperative laboratory changes, even though no single procedure type emerged as conferring a distinctly higher clinical risk once these correlations were accounted for³. These findings collectively suggest that anatomic region and the extent of tissue undermining and resection may modulate the clinical expression of metabolic risk as much as the metabolic risk factors themselves, a consideration that should inform procedure selection and staging decisions in patients with multiple cardiometabolic comorbidities.

Pathophysiological mechanisms linking metabolic syndrome to impaired wound healing:

Several mechanistic reviews included in this synthesis provide biological plausibility for the clinical associations described above. Obesity is associated with well-characterized anatomic, vascular, cellular, and molecular alterations that collectively impair surgical wound healing, including relative tissue hypoperfusion, oxidative stress, altered immune-mediator expression, and nutritional deficiencies¹⁷. Hypertrophic, dysfunctional adipocytes within expanded subcutaneous adipose tissue generate a chronic, low-grade pro-inflammatory state characterized by increased leptin production, a predominance of pro-inflammatory M1-polarized macrophages, and elevated circulating cytokines, alongside a reciprocal reduction in adiponectin and anti-inflammatory M2 macrophages; this inflammatory milieu disrupts the normal endothelial tip-cell interactions required for angiogenesis and reduces the ratio and cross-linking of type I to type III collagen, thereby decreasing the tensile strength of healing tissue^18,19. Adipose-derived stromal and stem cells, which under normal conditions contribute meaningfully to dermal regeneration and wound re-epithelialization, exhibit altered migratory behavior and immunophenotype when situated within a hypoxic, inflamed, obese adipose microenvironment, potentially further compromising local tissue regeneration and flap viability after extensive undermining, as occurs in abdominoplasty and body-lift procedures²¹. Collectively, these mechanistic data provide a coherent biological rationale for the clinically observed gradient of wound-healing complications across increasing degrees of adiposity and metabolic dysfunction described in the clinical studies above.

DISCUSSION

This systematic review synthesizes a heterogeneous but converging body of evidence indicating that metabolic syndrome and its constituent components exert a measurable, though variably quantified, influence on the safety of body contouring surgery. Several important themes emerge from this synthesis that merit further discussion.

Reconciling divergent effect sizes across study designs:

A notable pattern in the reviewed literature is the apparent discrepancy between single-institution cohort studies, which consistently report large, statistically robust associations between obesity, diabetes, and wound-related complications and large national database analyses using composite, code-based MetS definitions, which report comparatively attenuated effects limited chiefly to length of stay and readmission rather than major complication rates^{4,5,6,7,8,9,10}. Several explanations may account for this discrepancy. First, administrative databases such as NSQIP capture only 30-day outcomes, potentially missing later wound complications such as delayed dehiscence or chronic seroma that would be captured in single-institution cohorts with longer follow-up. Second, propensity-score matching in database studies, while reducing confounding, necessarily restricts the analytic sample to a subset of patients with comparable baseline characteristics, which may attenuate the observed effect of MetS by design. Third, and perhaps most importantly, the surrogate definitions of MetS used in most database studies typically BMI greater than 30 kg/m2 combined with pharmacologically treated diabetes and hypertension omit the lipid and waist-circumference criteria central to the harmonized diagnostic definition, likely resulting in both misclassification and dilution of the true exposure group¹. It is plausible that patients meeting the full harmonized criteria for MetS, particularly those with more severe insulin resistance and dyslipidemia, represent a physiologically distinct and higher-risk subgroup than the broader, code-defined MetS cohorts analyzed in most database studies to date.

Across nearly every study design examined in this review, obesity and diabetes mellitus considered individually emerge as the most consistent and reproducible predictors of wound-related morbidity, with a clear dose-response relationship between increasing BMI category and complication rate^7,9,10. This finding has direct clinical relevance: rather than relying solely on a binary MetS diagnosis, surgeons may derive more actionable risk information by assessing the severity of obesity and the degree of glycemic control individually. However, the finding that glycemic control, as measured by HbA1c, did not clearly stratify surgical-site infection risk in at least one contemporary cohort suggests that the relationship between hyperglycemia and wound healing is not simply linear, and that vascular disease burden, diabetes duration, and other unmeasured comorbidities may modulate this relationship in ways not yet fully captured by existing studies⁶.

The management of VTE risk in body-contouring patients with obesity or MetS exemplifies the broader clinical tension inherent in this field: interventions intended to reduce one category of risk (thromboembolism) can plausibly increase another (bleeding and hematoma)^12,13. The observation that most VTE events in plastic surgery occur among patients with relatively low Caprini scores argues against an over-reliance on any single risk-stratification instrument and supports a more individualized approach that considers procedure type (circumferential versus non-circumferential), operative duration, degree of intraoperative blood loss, and patient mobility, in addition to formal scoring^14,15. The demonstrated benefit of systematic, protocolized risk-assessment tools embedded within clinical workflows in other surgical specialties20 suggests that similar structured approaches, tailored specifically to body-contouring procedures and validated in this population, could meaningfully reduce VTE-related morbidity without proportionately increasing bleeding complications.

Patients presenting for body contouring after substantial bariatric-surgery-induced weight loss represent a population whose risk profile cannot be fully explained by BMI or MetS status alone. The amount and method of prior weight loss, the interval since bariatric surgery, residual nutritional deficiencies, the degree of skin and soft-tissue excess, and the number of concurrent procedures performed all contribute independently to complication risk^3,11. Reassuringly, at least one contemporary analysis found no clinically significant, procedure-independent laboratory abnormalities predictive of perioperative risk in this population, suggesting that with appropriate nutritional screening and staged surgical planning, the elevated risk historically attributed to massive weight loss patients may be substantially mitigated³. This underscores the importance of a multidisciplinary approach, involving bariatric surgery, nutrition, and plastic surgery teams, in the preoperative evaluation of this specific subgroup.

A recurring theme across both the liposuction-specific and the VTE-focused literature is that combining multiple body-contouring procedures into a single operative setting increases complication risk more consistently than any single metabolic risk factor considered in isolation^12,16. This has direct practical implications for patients with metabolic syndrome or its components: staging procedures, rather than combining them, may represent a more prudent strategy for higher-risk candidates, even though this approach carries the trade-off of additional anesthetic exposures and a longer overall treatment timeline. The decision to stage versus combine procedures should therefore be individualized based on the patient’s specific constellation of metabolic risk factors rather than applied uniformly.

The pathophysiological literature reviewed here provides a coherent biological narrative that helps explain the clinical observations described above: chronic adipose-tissue inflammation, adipokine dysregulation, impaired angiogenesis, and altered collagen architecture collectively create a wound-healing environment that is measurably less favorable in patients with obesity and metabolic dysfunction^17,18,19,21. These mechanistic insights raise the possibility that future perioperative interventions targeting inflammation, adipokine signaling, or the regenerative capacity of adipose-derived stem cells could meaningfully reduce complication rates in this population, though such interventions remain largely investigational and were outside the scope of the clinical outcome studies reviewed here.

The mechanistic findings synthesized in this review are not unique to body contouring surgery but rather reflect a broader, well-described phenomenon in general surgery. Obesity increases the incidence of incisional hernia after laparotomy by approximately three-fold, and the proposed mechanism a pro-inflammatory adipose-tissue state characterized by elevated leptin, an excess of M1-polarized macrophages, and a reduction in adiponectin and M2 macrophages, which together impair angiogenesis and reduce the tensile strength of the extracellular matrix through an altered collagen I-to-III ratio closely parallels the mechanisms proposed to explain wound dehiscence and delayed healing after abdominoplasty and panniculectomy¹⁹. This convergence between the general surgical and plastic surgical literature strengthens the biological plausibility of the clinical associations reported in the body-contouring-specific studies reviewed here, and suggests that strategies developed to mitigate incisional hernia risk in obese general surgery patients such as targeted preoperative weight optimization, mesh reinforcement in appropriate candidates, and meticulous fascial closure technique may have direct translational relevance to abdominal body-contouring surgery in patients with metabolic syndrome.

Beyond the direct clinical consequences to individual patients, the finding that metabolic syndrome is associated with a significantly longer hospital length of stay and a nearly two-fold increase in 30-day readmission risk after abdominal body contouring carries important implications for health-system resource allocation⁴. Readmissions in this population were driven predominantly by medical, rather than purely surgical, causes, suggesting that the observed effect of MetS may relate as much to the general perioperative fragility conferred by cardiometabolic dysregulation for instance, impaired glycemic control, blood pressure lability, or subclinical cardiovascular disease as to any direct effect on the surgical wound itself. This distinction has practical implications for perioperative pathways: enhanced postoperative medical monitoring, rather than surgical-site-specific interventions alone, may be the more impactful lever for reducing readmissions in patients with metabolic syndrome undergoing body contouring surgery. As the prevalence of metabolic syndrome continues to rise in parallel with global obesity rates, these downstream costs are likely to become an increasingly significant consideration for surgical practices and health systems planning to accommodate the growing demand for body-contouring procedures².

Based on the totality of evidence reviewed, several practical recommendations can be reasonably derived for the perioperative management of patients with metabolic syndrome or its components who are candidates for body contouring surgery: (1) preoperative optimization of glycemic control, blood pressure, and lipid parameters should be pursued in conjunction with the patient’s primary care or endocrinology team, with particular attention to weight stability for at least three months prior to surgery in massive-weight-loss patients; (2) individualized VTE risk stratification, combining a validated instrument such as the Caprini model with clinical judgment regarding procedure type, operative duration, and bleeding risk, should guide the selective use of mechanical and pharmacologic thromboprophylaxis; (3) staged, rather than combined, procedures should be considered for patients with multiple concurrent metabolic risk factors, particularly when liposuction is to be combined with abdominoplasty or when circumferential body-lift procedures are planned; (4) realistic preoperative counseling regarding the elevated, though generally manageable, risk of wound-related complications should be provided to patients with obesity, diabetes, or formally diagnosed MetS; and (5) postoperative surveillance protocols should account for the observed increase in hospital length of stay and readmission risk in this population, with particular attention to medical, rather than purely surgical, causes of readmission.

Several limitations of the reviewed literature warrant acknowledgment. First, the overwhelming majority of included studies are retrospective in design, introducing the potential for selection bias and residual confounding despite the use of multivariate adjustment or propensity-score matching in several analyses. Second, the definitional heterogeneity of metabolic syndrome across studies, discussed extensively above, substantially limits direct comparability of effect estimates. Third, administrative-database studies are inherently constrained by the accuracy and completeness of diagnostic and procedural coding, and typically capture only short-term (30-day) outcomes, potentially underestimating the true burden of delayed wound complications. Fourth, publication bias favoring studies with statistically significant or clinically notable findings cannot be excluded. Finally, this review itself did not perform formal quantitative meta-analysis or pooled effect-size estimation, given the substantial clinical and methodological heterogeneity across the included studies, and should therefore be interpreted as a qualitative, narrative synthesis rather than a meta-analytic one.

It is worth noting, as a forward-looking observation rather than a conclusion drawn directly from the studies reviewed here, that the population of patients presenting for body-contouring surgery is itself evolving. The expanding use of bariatric surgical techniques and non-surgical weight-management strategies means that increasing numbers of candidates will present having already achieved substantial reductions in body mass index, blood pressure, and glycemic parameters, potentially resolving some components of metabolic syndrome even while residual skin and soft-tissue excess persists as the primary indication for surgery. Whether such patients who may no longer meet formal criteria for metabolic syndrome despite a history of severe obesity carry a residual elevated surgical risk profile distinct from patients who have never met criteria for the syndrome is a question not directly answered by the studies reviewed here, but one that follows naturally from the observation that both the degree and the duration of prior metabolic dysfunction may independently influence tissue quality and healing capacity. This underscores the importance of longitudinal, rather than purely cross-sectional, characterization of metabolic status when evaluating body-contouring surgical candidates going forward.

FUTURE RESEARCH DIRECTIONS

Future research in this field would benefit substantially from the prospective application of harmonized, internationally accepted diagnostic criteria for metabolic syndrome,1 ideally within multicenter registries specifically designed to capture body-contouring outcomes with follow-up extending beyond the conventional 30-day postoperative window. Prospective evaluation of procedure-specific VTE risk-stratification and thromboprophylaxis algorithms, validated specifically within body-contouring populations, would help resolve the current uncertainty regarding optimal chemoprophylaxis practices. Additionally, mechanistic studies exploring whether preoperative optimization of adipose-tissue inflammation or adipokine profiles can measurably improve wound-healing outcomes represent a promising, though currently underexplored, avenue for future investigation.

CONCLUSIONS

Metabolic syndrome and its individual components central obesity, hypertension, dyslipidemia, and hyperglycemia meaningfully influence the risk of complications following body contouring surgery, though the magnitude of this influence varies considerably depending on how the syndrome is defined and how outcomes are measured. Obesity and diabetes mellitus, evaluated individually, demonstrate the most consistent and clinically actionable association with wound-related morbidity, following a clear dose-response pattern across the severity of obesity. When metabolic syndrome is evaluated as a composite diagnosis using large administrative databases, its effect appears more modest, manifesting primarily as increased hospital length of stay and 30-day readmission rather than a substantially higher rate of major surgical complications, suggesting that well-selected patients with metabolic syndrome can safely undergo body contouring procedures under appropriate perioperative management. Venous thromboembolism, while rare, remains disproportionately associated with obesity and circumferential or combined procedures, and current risk-stratification tools, while useful, are imperfect predictors that should be supplemented by clinical judgment. Chronic adipose-tissue inflammation and adipokine dysregulation offer a plausible biological explanation for the clinically observed impairment in wound healing among patients with metabolic dysfunction. Given the substantial heterogeneity in how metabolic syndrome has been defined across the existing literature, future research employing standardized, harmonized diagnostic criteria and longer-term, prospective outcome measures is needed to refine risk stratification and optimize the safety of body contouring surgery in this growing and increasingly complex patient population.

 

REFERENCES

1. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5. doi: 10.1161/CIRCULATIONAHA.109.192644.
2. Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. doi: 10.1007/s11906-018-0812-z.
3. Stumpfe MC, Platzer J, Horch RE, Geierlehner A, Arkudas A, Mueller-Seubert W, et al. Analysis of laboratory markers in body contouring procedures after bariatric surgery does not indicate particular risks for perioperative complications. Perioper Med (Lond). 2024;13(1):63. doi: 10.1186/s13741-024-00422-7.
4. Escobar-Domingo MJ, Taritsa IC, Mahmoud AA, Fanning JE, Hernandez Alvarez A, Escobar-Domingo DP, et al. The impact of metabolic syndrome on postoperative outcomes in abdominal body contouring: a propensity score-matched nationwide analysis. Aesthetic Plast Surg. 2024;48(20):4168-77. doi: 10.1007/s00266-024-04227-3.
5. Zavlin D, Jubbal KT, Balinger CL, Dinh TA, Friedman JD, Echo A. Impact of metabolic syndrome on the morbidity and mortality of patients undergoing panniculectomy. Aesthetic Plast Surg. 2017;41(6):1400-7. doi: 10.1007/s00266-017-0952-6.
6. Kennedy PJ, Olson MA, Kaptsan II, Bernard J, Ormseth B, Janis JE. Impact of diabetes medications and HbA1c levels on abdominoplasty and panniculectomy outcomes. JPRAS Open. 2025;46:712-22. doi: 10.1016/j.jpra.2025.09.028.
7. Brito ÍM, Meireles R, Baltazar J, Brandão C, Sanches F, Freire-Santos MJ. Abdominoplasty and patient safety: the impact of body mass index and bariatric surgery on complications profile. Aesthetic Plast Surg. 2020;44(5):1615-24. doi: 10.1007/s00266-020-01725-y.
8. Montesanti B, Kahhaleh E, De Mey A. Experience of abdominoplasty and analysis of the risk factors. Acta Chir Belg. 2022;122(1):1-6. doi: 10.1080/00015458.2021.2014034.
9. Garoosi K, Mundra L, Jabbari K, Winocour J, Iorio ML, Mathes DW. Comorbid conditions and complications in body contouring surgery: a retrospective review. Aesthet Surg J Open Forum. 2023;5:ojad080. doi: 10.1093/asjof/ojad080.
10. Au K, Hazard SW 3rd, Dyer AM, Boustred AM, Mackay DR, Miraliakbari R. Correlation of complications of body contouring surgery with increasing body mass index. Aesthet Surg J. 2008;28(4):425-9. doi: 10.1016/j.asj.2008.04.003.
11. Constantine RS, Davis KE, Kenkel JM. The effect of massive weight loss status, amount of weight loss, and method of weight loss on body contouring outcomes. Aesthet Surg J. 2014;34(4):578-83. doi: 10.1177/1090820X14528208.
12. Yin C, McAuliffe PB, Marquez JE, Liao CD, Vasilakis V, Estrella J, et al. Body contouring in massive weight loss patients receiving venous thromboembolism chemoprophylaxis: a systematic review. Plast Reconstr Surg Glob Open. 2021;9(8):e3746. doi: 10.1097/GOX.0000000000003746.
13. Khatri A, Davies AH, Shalhoub J. Mechanical prophylaxis for venous thromboembolism prevention in obese individuals. Phlebology. 2021;36(10):768-70. doi: 10.1177/02683555211031147.
14. Swanson E. Reconsidering the value of Caprini scores and venous thromboembolism (VTE) risk mitigation methods in plastic surgery patients. Aesthetic Plast Surg. 2023;47(Suppl 1):223-7. doi: 10.1007/s00266-023-03261-x.
15. Claytor RB, Tolan G, Pettibone T, Fisher A. A comprehensive mechanical and chemoprophylaxis algorithm for prevention of venous thromboembolism in lipoabdominoplasty. Aesthet Surg J Open Forum. 2025;7:ojaf024. doi: 10.1093/asjof/ojaf024.
16. Barros LFL, Teixeira VF, Reis JAP, Ferraz RA, Araújo DC, Vendramin FS. Complications in liposuction: systematic review. Rev Bras Cir Plást. 2023;38:e0641. doi: 10.5935/2177-1235.2023RBCP0641-EN.
17. Pierpont YN, Dinh TP, Salas RE, Johnson EL, Wright TG, Robson MC, et al. Obesity and surgical wound healing: a current review. ISRN Obes. 2014;2014:638936. doi: 10.1155/2014/638936.
18. Alma A, Marconi GD, Rossi E, Magnoni C, Paganelli A. Obesity and wound healing: focus on mesenchymal stem cells. Life (Basel). 2023;13(3):717. doi: 10.3390/life13030717.
19. Kenny MG, Agrawal S, Crigler C, Fitzgibbons RJ. A molecular perspective of obesity-mediated incisional hernia. Health Sci Rev. 2023;6:100080. doi: 10.1016/j.hsr.2023.100080.
20. Rastogi R, Lattimore CM, Mehaffey JH, Turrentine FE, Maitland HS, Zaydfudim VM. Electronic health record risk-stratification tool reduces venous thromboembolism events in surgical patients. Surg Open Sci. 2022;9:34-40. doi: 10.1016/j.sopen.2022.04.003.
21. Trevor LV, Riches-Suman K, Mahajan AL, Thornton MJ. Adipose tissue: a source of stem cells with potential for regenerative therapies for wound healing. J Clin Med. 2020;9(7):2161. doi: 10.3390/jcm9072161.